EZH2 and colorectal carcinoma: These data suggest that inhibiting the catalytic activity of EZH2 alone has little effect on gene expression whereas AKT activation through PTEN KD induces transcriptional reprogramming to mediate a transition to a more mesenchymal phenotype in epithelial CMS3 CRC.